Cubist discloses DOJ, SEC investigations of Optimer payments
Cubist Pharmaceuticals Inc. said Monday that a global biopharmaceutical company it bought in 2013 may have violated the FCPA.
Lexington, Massachusetts-based Cubist acquired Optimer Pharmaceuticals late last year for $551 million.… Continue Reading